Evaluation Of Tacrolimus, Associated Adverse Effects, Quality Of Life, And Treatment Satisfaction Among Kidney Transplant Patients In Riyadh, Saudi Arabia

The number of renal transplanted patients in Saudi Arabia is markedly increased. Tacrolimus is a well-known immunosuppressive drug used to prevent allograft rejection. Due to tacrolimus- unwanted adverse effects, narrow therapeutic index, drug-drug interactions, and significant inter-individual vari...

Full description

Bibliographic Details
Main Author: Ahmed Alboghdadly, Amany Mohamed Hussien
Format: Thesis
Language:English
Published: 2023
Subjects:
Online Access:http://eprints.usm.my/60157/1/24%20Pages%20from%20AMANY%20MOHAMED%20HUSSIEN%20AHMED%20ALBOGHDADLY.pdf
_version_ 1825908226485387264
author Ahmed Alboghdadly, Amany Mohamed Hussien
author_facet Ahmed Alboghdadly, Amany Mohamed Hussien
author_sort Ahmed Alboghdadly, Amany Mohamed Hussien
collection USM
description The number of renal transplanted patients in Saudi Arabia is markedly increased. Tacrolimus is a well-known immunosuppressive drug used to prevent allograft rejection. Due to tacrolimus- unwanted adverse effects, narrow therapeutic index, drug-drug interactions, and significant inter-individual variability in pharmacokinetics, it requires constant therapeutic drug monitoring. This study aims to determine the tacrolimus-associated adverse effects and the factors associated with their occurrence, acute cellular rejection, and graft loss. Also, to evaluate the relationship between tacrolimus trough concentration (FK506-C0) levels with all of these variables. Finally, the effect of demographic, clinical, and social factors on health-related quality of life (HRQoL) and treatment satisfaction in tacrolimus-treated patients’ post-renal transplantation (RTP) in Saudi population was investigated. It is a pre-experimental study design conducted at the Security Forces Hospital in Riyadh, Saudi Arabia. The study included all patients over the age of 18 who received a kidney transplant between January 2006 and January 2019 and were treated with tacrolimus, mycophenolate mofetil, and prednisolone (322 patients). Patients were monitored at each clinic visit and followed up until September 2019
first_indexed 2024-04-09T03:53:09Z
format Thesis
id usm.eprints-60157
institution Universiti Sains Malaysia
language English
last_indexed 2024-04-09T03:53:09Z
publishDate 2023
record_format dspace
spelling usm.eprints-601572024-03-13T01:39:44Z http://eprints.usm.my/60157/ Evaluation Of Tacrolimus, Associated Adverse Effects, Quality Of Life, And Treatment Satisfaction Among Kidney Transplant Patients In Riyadh, Saudi Arabia Ahmed Alboghdadly, Amany Mohamed Hussien RS1-441 Pharmacy and materia medica The number of renal transplanted patients in Saudi Arabia is markedly increased. Tacrolimus is a well-known immunosuppressive drug used to prevent allograft rejection. Due to tacrolimus- unwanted adverse effects, narrow therapeutic index, drug-drug interactions, and significant inter-individual variability in pharmacokinetics, it requires constant therapeutic drug monitoring. This study aims to determine the tacrolimus-associated adverse effects and the factors associated with their occurrence, acute cellular rejection, and graft loss. Also, to evaluate the relationship between tacrolimus trough concentration (FK506-C0) levels with all of these variables. Finally, the effect of demographic, clinical, and social factors on health-related quality of life (HRQoL) and treatment satisfaction in tacrolimus-treated patients’ post-renal transplantation (RTP) in Saudi population was investigated. It is a pre-experimental study design conducted at the Security Forces Hospital in Riyadh, Saudi Arabia. The study included all patients over the age of 18 who received a kidney transplant between January 2006 and January 2019 and were treated with tacrolimus, mycophenolate mofetil, and prednisolone (322 patients). Patients were monitored at each clinic visit and followed up until September 2019 2023-07 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/60157/1/24%20Pages%20from%20AMANY%20MOHAMED%20HUSSIEN%20AHMED%20ALBOGHDADLY.pdf Ahmed Alboghdadly, Amany Mohamed Hussien (2023) Evaluation Of Tacrolimus, Associated Adverse Effects, Quality Of Life, And Treatment Satisfaction Among Kidney Transplant Patients In Riyadh, Saudi Arabia. PhD thesis, Perpustakaan Hamzah Sendut.
spellingShingle RS1-441 Pharmacy and materia medica
Ahmed Alboghdadly, Amany Mohamed Hussien
Evaluation Of Tacrolimus, Associated Adverse Effects, Quality Of Life, And Treatment Satisfaction Among Kidney Transplant Patients In Riyadh, Saudi Arabia
title Evaluation Of Tacrolimus, Associated Adverse Effects, Quality Of Life, And Treatment Satisfaction Among Kidney Transplant Patients In Riyadh, Saudi Arabia
title_full Evaluation Of Tacrolimus, Associated Adverse Effects, Quality Of Life, And Treatment Satisfaction Among Kidney Transplant Patients In Riyadh, Saudi Arabia
title_fullStr Evaluation Of Tacrolimus, Associated Adverse Effects, Quality Of Life, And Treatment Satisfaction Among Kidney Transplant Patients In Riyadh, Saudi Arabia
title_full_unstemmed Evaluation Of Tacrolimus, Associated Adverse Effects, Quality Of Life, And Treatment Satisfaction Among Kidney Transplant Patients In Riyadh, Saudi Arabia
title_short Evaluation Of Tacrolimus, Associated Adverse Effects, Quality Of Life, And Treatment Satisfaction Among Kidney Transplant Patients In Riyadh, Saudi Arabia
title_sort evaluation of tacrolimus associated adverse effects quality of life and treatment satisfaction among kidney transplant patients in riyadh saudi arabia
topic RS1-441 Pharmacy and materia medica
url http://eprints.usm.my/60157/1/24%20Pages%20from%20AMANY%20MOHAMED%20HUSSIEN%20AHMED%20ALBOGHDADLY.pdf
work_keys_str_mv AT ahmedalboghdadlyamanymohamedhussien evaluationoftacrolimusassociatedadverseeffectsqualityoflifeandtreatmentsatisfactionamongkidneytransplantpatientsinriyadhsaudiarabia